What Researchers Did
Researchers compared hyperbaric oxygen therapy plus standard medical therapy to standard medical therapy alone in patients with sudden hearing loss.
What They Found
Success rates were 78.95% for patients receiving hyperbaric oxygen therapy plus standard treatment, compared to 71.30% for those receiving standard treatment alone. This difference was not statistically significant (p > 0.05).
What This Means for Canadian Patients
Given the lack of significant benefit, cost, and inconvenience, hyperbaric oxygen therapy may not be a primary treatment for sudden hearing loss. It should only be considered for patients who cannot receive standard medical treatment due to contraindications.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's relatively small sample size may have limited its ability to detect a statistically significant difference.